Psychische Gesundheit bei Kindern und Jugendlichen mit rheumatischen Erkrankungen

ZUSAMMENFASSUNG

Kinder und Jugendliche mit chronischen rheumatischen Erkrankungen erleben oft vielfältige Belastungen, wie Schmerzen, Funktionsstörungen, Nebenwirkungen von Medikamenten, und sind nicht selten durch zeitintensive Therapien und Arztbesuche in ihrem sozialen Leben beeinträchtigt. So kann – trotz immer besserer Therapiemöglichkeiten – auch die psychische Gesundheit leiden. Verschiedene Forschungsverbünde (z. B. COACH) und Studien (z. B. KickCOVID) widmen sich zurzeit mittels spezifischer Fragebögen psychischen Symptomen von Kindern und Jugendlichen mit verschiedenen chronischen Erkrankungen (z. B. Mukoviszidose, juvenile idiopathische Arthritis, Typ-1-Diabetes). Psychische Komorbiditäten können im Kontext einer chronischen Erkrankung zu einer schlechteren Lebensqualität sowie zu einer geringeren Therapieadhärenz führen, welche wiederum das Outcome der Grunderkrankung beeinträchtigt. Eine umfassende Versorgung chronisch kranker junger Menschen sollte daher ein standardisiertes Screening auf psychische Komorbiditäten im Rahmen routinemäßiger Verlaufskontrollen beinhalten.

ABSTRACT

Children and adolescents with chronic rheumatic diseases often experience a variety of stresses, such as pain, dysfunctions, side effects of medication, and their social life is often impaired by time-consuming therapies and doctor’s visits. Thus – despite increasingly better therapy options – mental health can also be affected. Various research networks (e. g. COACH) and studies (e. g. KickCOVID) are currently addressing psychological symptoms of children and adolescents with various chronic diseases (e. g. cystic fibrosis, juvenile idiopathic arthritis, type 1 diabetes) by means of specific questionnaires. Psychological comorbidities in the context of a chronic disease can lead to a poorer quality of life as well as to a lower adherence to therapy, which in turn impairs the outcome of the underlying disease. Comprehensive care for chronically ill young people should therefore include standardised screening for mental comorbidities as part of routine follow-up.

Schlüsselwörter

Psychische Gesundheit - Depression - Angststörung - rheumatische Erkrankung - juvenile idiopathische Arthritis

Keywords

Mental health - depression - anxiety disorder - rheumatic disease - juvenile idiopathic arthritis

Publication History

Article published online:
09 December 2022

• Literatur

• 1 Hölling H, Dippelhofer Schlack R. et al Personale, familiäre und soziale Schutzfaktoren und gesundheitsbezogene Lebensqualität chronisch kranker Kinder und Jugendlicher. Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz 2008; 51: 606-620
• 2 Luque Ramos A, Hoffmann F, Albrecht K. et al Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis. Semin Arthritis Rheum 2017; 47 (02) 269-275
• 3 Zink A, Albrecht K. Wie häufig sind muskuloskeletale Erkrankungen in Deutschland? [How frequent are musculoskeletal diseases in Germany?]. Z Rheumatol 2016; 75 (04) 346-353
• 4 Glerup M, Rypdal V, Arnstad ED. et al Long-Term Outcomes in Arthritis Care Res (Hoboken). 2020; 72 (04) 507-516
• 5 Chédeville G, McGuire K, Cabral DA. et al Parent-Reported Medication Side Effects and Their Impact on Health-Related Quality of Life in Children With. Arthritis Care Res (Hoboken). 2021 Mar 30
• 6 Jansson S, Malham M, Wewer V, Rask CU.. Psychiatric comorbidity in childhood onset immune-mediated diseases – A systematic review and meta-analysis.
• 7 Mullick MS, Nahar JS, Haq SA. Psychiatric morbidity, stressors, impact, and burden in juvenile idiopathic arthritis. J Health Popul Nutr 2005; 23 (02) 142-149
• 8 Bomba M, Meini A, Molinaro A. et al Body experiences, emotional competence, and psychosocial functioning in juvenile idiopathic arthritis. Rheumatol Int 2013; 33 (08) 2045-2052
• 9 Krause ML, Zamora-Legoff JA, Crowson CS. et al Population-based study of outcomes of patients with juvenile idiopathic arthritis (JIA) compared to non-JIA subjects. Semin Arthritis Rheum 2017; 46 (04) 439-443
• 10 Oommen PT, Klotsche J, Dressler F. et al Frequency of depressive and anxious symptoms in patients with juvenile idiopathic arthritis (JIA) – Data from the Inception Cohort of Newly diagnosed patients with JIA (ICON). Annals of Rheumatic Diseases 2022; 81 (Suppl. 01) 143
• 11 Tarakci E, Yeldan I, Kaya Mutlu E. et al The relationship between physical activity level, anxiety, depression, and functional ability in children and adolescents with juvenile idiopathic arthritis. Clin Rheumatol 2011; 30 (11) 1415-1420
• 12 Ding T, Hall A, Jacobs K. et al Psychological functioning of children and adolescents with juvenile idiopathic arthritis is related to physical disability but not to disease status. Rheumatology (Oxford) 2008; 47 (05) 660-664
• 13 Ivarsson T, Gillberg C. Depressive symptoms in Swedish adolescents: normative data using the Birleson Depression Self-Rating Scale (DSRS). J Affect Disord 1997; 42 (01) 59-68
• 14 Hanns L, Radziszewska A, Suffield L. et al Association of Anxiety With Pain and Disability but Not With Increased Measures of Inflammation in Adolescent Patients With Juvenile Idiopathic Arthritis. Arthritis Care Res (Hoboken) 2020; 72 (09) 1266-1274
• 15 Barican JL, Yung D, Schwartz C. et al Prevalence of childhood mental disorders in high-income countries: a systematic review and meta-analysis to inform policymaking. Evid Based Ment Health 2022; 25 (01) 36-44
• 16 Shorey S, Ng ED, Wong CHJ. Global prevalence of depression and elevated depressive symptoms among adolescents: A systematic review and meta-analysis. Br J Clin Psychol 2022; 61 (02) 287-305
• 17 Fair DC, Nocton JJ, Panepinto JA. et al Anxiety and Depressive Symptoms in Juvenile Idiopathic Arthritis Correlate With Pain and Stress Using PROMIS Measures. J Rheumatol 2022; 49 (01) 74-80
• 18 Hanns L, Cordingley L, Galloway J. et al Depressive symptoms, pain and disability for adolescent patients with juvenile idiopathic arthritis: results from the Childhood Arthritis Prospective Study Rheumatology (Oxford). 2018; 57 (08) 1381-1389
• 19 Castaneda AE, Tuulio-Henriksson A, Aronen ET. et al Cognitive functioning and depressive symptoms in adolescents with inflammatory bowel disease. World J Gastroenterol 2013; 19 (10) 1611-1617
• 20 Kuburovic NB, Pasic S, Susic G. et al Health-related quality of life, anxiety, and depressive symptoms in children with primary immunodeficiencies. Patient Prefer Adherence 2014; 08: 323-330
• 21 Graziano S, Rossi A, Spano B. et al Comparison of psychological functioning in children and their mothers living through a life-threatening and non life-threatening chronic disease: A pilot study. J Child Health Care 2016; 20 (02) 174-184
• 22 Quilter MC, Hiraki LT and Korczak DJ. Depressive and anxiety symptom prevalence in childhood-onset systemic lupus erythematosus: A systematic review. Lupus 2019; 28: 878-887
• 23 Stevanovic D, Susic G. Health-related quality of life and emotional problems in juvenile idiopathic arthritis. Qual Life Res 2013; 22 (03) 607-612
• 24 Abdul-Sattar AB, Elewa EA, El-Dessoky El-Shahawy E. et al Determinants of health-related quality of life impairment in Egyptian children and adolescents with juvenile idiopathic arthritis: Sharkia Governorate. Rheumatol Int 2014; 34 (08) 1095-1101
• 25 Donnelly C, Cunningham N, Jones JT. et al Fatigue and Depression Predict Reduced Health-Related Quality of Life in Childhood-Onset Lupus. Lupus 2018; 27 (01) 124-133
• 26 Di Matteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160 (14) 2101-2107
• 27 Zheng K, Abraham C, Bruzzese JM. et al Longitudinal Relationships Between Depression and Chronic Illness in Adolescents: An Integrative Review. J Pediatr Health Care 2020; 34 (04) 333-345
• 28 Davis AM, Graham TB, Zhu Y. et al Depression and medication nonadherence in childhood-onset systemic lupus erythematosus. Lupus 2018; 27 (09) 1532-1541
• 29 Rubinstein TB, Dionizovik-Dimanovski M, Davis AM. et al Multicenter study of utility and acceptability of depression and anxiety screening in adolescents and young adults with childhood-onset systemic lupus.
• 30 Lunkenheimer F, Domhardt M, Geirhos A. et al Effectiveness and cost-effectiveness of guided Internet- and mobile-based CBT for adolescents and young adults with chronic somatic conditions and comorbid depression and anxiety symptoms (youthCOACH Trials. 2020; 21 (01) 253
• 31 Niewerth M, Eulert S, Hörstermann J. et al Prävalenz von psychischen Erkrankungen bei Jugendlichen und jungen Erwachsenen mit juveniler idiopathischer Arthritis (JIA) in der rheumatologischen Routineversorgung – Erste Ergebnisse aus dem Verbundprojekt COACH. Monatsschr Kinderheilkd 2021; 169 (Suppl. 03) S188
• 32 Köstner K, Geirhos A, Ranz R. et al Angst und Depression bei Typ-1-Diabetes – Erste Ergebnisse des Screenings auf psychische Komorbiditäten bei Jugendlichen und jungen Erwachsenen im Rahmen des COACH-Konsortiums. Diabetologie 2022; 17: 197-207
• 33 Göldel JM, Wiegand S, Minden K. et al Kinder und Jugendliche mit chronischen Erkrankungen in der COVID-19-Pandemie – eine vergessene Gruppe?. Kinder- und Jugendarzt 2022; 53: 4
• 34 www.awmf.org/leitlinien/detail/11/057-016.html
• 35 Cameron FJ, Northam EA, Ambler GR. et al Routine psychological screening in youth with type 1 diabetes and their parents: a notion whose time has come?. Diabetes Care 2007; 30 (10) 2716-2724
• 36 Quittner AL, Abbott J, Georgiopoulos AM. et al International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety. Thorax 2016; 71 (01) 26-34